Preferred Label : Fluorouracil/Liposomal Irinotecan/Leucovorin/Oxaliplatin Regimen;
NCIt synonyms : Folinic Acid/Fluorouracil/Onivyde/Oxaliplatin; Folinic Acid/5-FU/Liposomal Irinotecan/Oxaliplatin; Leucovorin/Fluorouracil/Liposomal Irinotecan/Oxaliplatin Regimen; Fluorouracil/Folinic Acid/Nanoliposomal Irinotecan/Oxaliplatin; Leucovorin-Fluorouracil-Liposomal Irinotecan-Oxaliplatin; Leucovorin/Fluorouracil/Onivyde/Oxaliplatin; Fluorouracil/Liposomal Irinotecan/Leucovorin/Oxaliplatin; Leucovorin-Fluorouracil-Liposomal Irinotecan-Oxaliplatin Regimen; Fluorouracil-Liposomal Irinotecan-Leucovorin-Oxaliplatin; Folinic Acid/Fluorouracil/Liposomal Irinotecan/Oxaliplatin; Fluorouracil Continuous Infusion/Leucovorin/Liposomal Irinotecan/Oxaliplatin; Nalirifox; NALIRIFOX Regimen;
NCIt definition : A regimen consisting of leucovorin, 5-fluorouracil, liposomal irinotecan and oxaliplatin
that may be used in the treatment of pancreatic adenocarcinoma.;
NCI Metathesaurus CUI : CL1922529;
Codes from synonyms : 124704;
Origin ID : C203711;
UMLS CUI : C5909415;
Semantic type(s)
- chemotherapy_regimen_has_component
- concept_is_in_subset
https://www.has-sante.fr/jcms/p_3633450/fr/onivyde-pegylated-liposomal-irinotecan-liposomal-pegyle-cancer-du-pancreas-metastatique
2025
false
false
false
France
irinotecan sucrosofate
treatment outcome
insurance, health, reimbursement
topoisomerase I inhibitors
antineoplastic agents
antineoplastic combined chemotherapy protocols
neoplasm metastasis
Metastatic Pancreatic Adenocarcinoma
adenocarcinoma
adult
Fluorouracil/Liposomal Irinotecan/Leucovorin/Oxaliplatin Regimen
evaluation of the transparency committee
pancreatic neoplasms
Irinotecan
---
